Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL1416120-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 10
- Deaths reported
- 1
- Injuries reported
- 9
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 10 adverse event reports that list this exact device (DI M701TVIL1416120J1), received between May 17, 2017 and Apr 3, 2023 — classified as 1 death, 9 injuries.
The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Improper or Incorrect Procedure or Method2
- Leak/Splash2
- Occlusion Within Device2
- Appropriate Device Problem Term/Code Not Available1
- Device Stenosis1
- Insufficient Device Problem Information1
- Migration1
- Off-Label Use1
Patient problems
- Failure of Implant7
- Aneurysm3
- Ischemia2
- Occlusion2
- Blood Loss1
- Claudication1
- Death1
- Intimal Dissection1
Recent adverse event reports
The 10 most recent of 10 reports, in the reporter's own words as published by the FDA.
InjuryApr 3, 2023Device Stenosis; Device Stenosis
THE PATIENT WAS TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE IMPLANT OF THE OVATION IX ABDOMINAL STENT GRAFT SYSTEM. APPROXIMATELY (4) FOUR YEARS POST-IMPLANT RIGHT LIMB THROMBOSIS WAS IDENTIFIED. REINTERVENTION IS PLANNED FOR AN OPEN THROMBECTOMY WITH RELINING OF THE LIMB AND STENTING OF THE PROXIMAL EXTERNAL ILIAC ARTERY, BUT SURGERY HAS NOT BEEN SCHEDULED. THE PATIENT IS CURRENTLY BEING MONITORED.
Patient problems: Thrombosis/Thrombus
MAUDE report 16665569 ↗InjurySep 19, 2022Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH IMPLANT OF THE ALTO ABDOMINAL AORTIC ANEURYSM STENT SYSTEM. APPROXIMATELY TWO (2) YEARS POST INITIAL PROCEDURE, THE PATIENT WAS ADMITTED TO THE HOSPITAL FOR A NON-AAA-RELATED CAUSE, AND SCAN IMAGING REVEALED A TYPE IB ENDOLEAK OF THE LEFT ILIAC. THE PHYSICIAN ELECTED TO TREAT THE PATIENT BY IMPLANTING TWO (2) ADDITIONAL OVATION IX ILIAC LIMBS IN BOTH ILIAC ARTERIES ON (B)(6) 2022. THE PATIENT IS REPORTEDLY IN STABLE CONDITION.
Patient problems: Aneurysm; Failure of Implant
MAUDE report 15452244 ↗InjuryFeb 9, 2021Improper or Incorrect Procedure or Method; Patient-Device Incompatibility; Improper or Incorrect Procedure or Method; Patient-Device Incompatibility
THE PATIENT WAS INITIALLY IMPLANTED WITH A AFX2 BIFURCATED STENT GRAFT, AN OVATION IX LIMB EXTENSION AND AN OVATION IX LIMB EXTENDER TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). THIS INITIAL PROCEDURE IS OUTSIDE THE INDICATIONS OF USE (OFF-LABEL) DUE TO THE USE OF ADJUNCTIVE DEVICES NOT COMPATIBLE WITH AFX2 SYSTEM PER THE IFU. APPROXIMATELY 1.5 YEAR POST INITIAL PROCEDURE, A TYPE 1B ENDOLEAK WAS IDENTIFIED DURING THE CLINICAL ASSESSMENT OF A PREVIOUS CASE REPORTED (2031527-2020-00368). THE PHYSICIAN ELECTED TO RELINE THE ORIGINAL IMPLANTED DEVICES WITH AN AFX2 BIFURCATED STENT GRAFT, VELA (AFX) INFRARENAL STENT GRAFT AND A VELA (AFX) SUPRARENAL STENT GRAFT TO RESOLVE THE REPORTED TYPE 1B ENDOLEAK. THE PATIENT WAS REPORTED AS STABLE POST RE-INTERVENTION.
Patient problems: Failure of Implant
MAUDE report 11305049 ↗DeathJan 8, 2021Insufficient Device Problem Information; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH AN OVATION IX STENT GRAFT SYSTEM AND TWO EXTENDERS TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY ONE (1) YEAR POST INITIAL PROCEDURE THE PATIENT PRESENTED SYMPTOMATIC TO THE EMERGENCY ROOM AND WITH WHAT APPEARS TO BE A JUNCTION LEAK (CLASSIFIED AS A TYPE IIIA ENDOLEAK) FROM THE 16X120 AND 16X45 LIMBS ON THE PATIENT'S RIGHT SIDE. THE PHYSICIAN REPAIRED THE ENDOLEAK WITH ANOTHER MANUFACTURER'S STENT GRAFTS ON (B)(6) 2020 AND THE ENDOLEAK WAS RESOLVED. THE PATIENT WAS REPORTED AS DOING FINE POST SECONDARY PROCEDURE.
Patient problems: Death; Failure of Implant; Rupture
MAUDE report 11139564 ↗InjuryAug 26, 2019Improper or Incorrect Procedure or Method; Migration; Improper or Incorrect Procedure or Method; Migration
THE PATIENT WAS INITIALLY TREATED EMERGENTLY WITH THE OVATION IX ABDOMINAL STENT GRAFT SYSTEM OUTSIDE THE INDICATIONS FOR USE. APPROXIMATELY 1-YEAR POST OP A COMPUTED TOMOGRAPHY REVEALED A LEFT TYPE IB ENDOLEAK. THE PHYSICIAN ELECTED TO TREAT THE PATIENT WITH A 22X160 OVATION ILIAC LIMB SUCCESSFULLY RESOLVING THE REPORTED ENDOLEAK. SUBSEQUENT TO THE INITIAL REPORT, CLINICAL ASSESSMENT DETERMINED THAT THERE WAS EVIDENCE TO REASONABLY SUGGEST LEFT OVATION LIMB STENT MIGRATION (PROXIMAL) OCCURRED THAT WAS NOT INCLUDED IN THE EVENT AS REPORTED.
Patient problems: Aneurysm
MAUDE report 8933022 ↗InjuryApr 23, 2019Unintended Movement; Unintended Movement
AN AFX2 BIFURCATED STENT GRAFT, AN AFX VELA SUPRARENAL, TWO (2) AFX LIMB STENT GRAFTS, AND AN OVATION IX ILIAC LIMB WERE IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). IN ADDITION, THE RIGHT HYPOGASTRIC ARTERY WAS COILED. APPROXIMATELY THREE (3) YEARS POST OP, A ROUTINE FOLLOW-UP CT IDENTIFIED AN ILIAC AAA (UNKNOWN DIAMETER) ON THE RIGHT SIDE AND THE OVATION IX ILIAC LIMB HAS MOVED UP INTO THE ILIAC AAA. RE-INTERVENTION WAS COMPLETED WITH IMPLANT OF AN OVATION ILIAC LIMB.
Patient problems: Aneurysm; Failure of Implant
MAUDE report 8542400 ↗InjuryAug 22, 2018Leak/Splash; Leak/Splash
ON (B)(6) 2018, THE PATIENT WAS IMPLANTED THE OVATION SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON (B)(4) 2018, ENDOLOGIX WAS MADE AWARE OF A TYPE 1B ENDOLEAK. ON (B)(6) 2018, THE PHYSICIAN ELECTED TO IMPLANT AN ADDITIONAL LLIAC LIMB. THE ENDOLEAK WAS RESOLVED. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant
MAUDE report 7806164 ↗InjuryJun 14, 2018Leak/Splash; Leak/Splash
ON (B)(6) 2018, THE OVATION ENDOVASCULAR SEALING SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON (B)(6) 2018, ENDOLOGIX WAS MADE AWARE A INDETERMINATE ENDOLEAK (POSSIBLE TYPE 2 OR 3A) WITH NO SAC GROWTH. NO FURTHER INFORMATION IS AVAILABLE AT THIS TIME. THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant
MAUDE report 7603970 ↗InjuryFeb 7, 2018Occlusion Within Device; Occlusion Within Device
AN OVATION IX ILIAC LIMB STENT GRAFT WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. PATIENT RETURNED FOR UNKNOWN REASON WHERE PHYSICIAN OBSERVED THROMBOSIS OF THE RIGHT LIMB. THE RIGHT LIMB WAS REPORTED TO HAVE COLLAPSED IN THE LEG OF THE MAIN BODY. THE PHYSICIAN ELECTED TO RE-INTERVENE BY EXPLANTING THE DEVICE, SUCCESSFULLY RESOLVING THE THROMBOSIS. THE PATIENT IS REPORTED TO BE DOING WELL POST-PROCEDURE. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Blood Loss; Claudication; Ischemia; Occlusion; Pain; Thrombosis
MAUDE report 7250080 ↗InjuryMay 17, 2017Occlusion Within Device; Off-Label Use; Occlusion Within Device; Off-Label Use
AN OVATION IX ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. PATIENT RETURNED EMERGENTLY WITH DIMINISHED PULSE IN THE RIGHT GROIN. PHYSICIAN ELECTED TO DO AN OPEN THROMBECTOMY OF THE RIGHT ILIAC. THE RIGHT LIMB WAS RELINED USING A 14X14X160 LIMB THAT EXTENDED DOWN INTO THE EXTERNAL ILIAC. UPON COMPLETION OF THE PROCEDURE, THE PHYSICIAN NOTED THAT THE RIGHT LIMB DID NOT FILL AS QUICKLY AS THE LEFT LIMB AND ELECTED TO EXTEND BOTH LIMBS INTO THE AORTIC BODY (KISSING LIMBS). THE PROCEDURE CONCLUDED WITHOUT ISSUES. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Failure of Implant; Intimal Dissection; Ischemia; Occlusion; Thrombus
MAUDE report 6572124 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page